Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2019

Shelley Wood

December 31, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

Presentation TCT Abstracts Posters 2019

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Presenter: Jihoon Kim

October 03, 2019

News Conference News ESC 2019

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Shelley Wood

September 01, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Todd Neale

August 21, 2019

News Daily News

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Michael O'Riordan

August 09, 2019

News Industry News

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

July 25, 2019

News Daily News

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Marcus A. Banks

July 24, 2019

News Conference News ESC Heart Failure 2019

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Shelley Wood

May 28, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Daily News

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Yael L. Maxwell

March 22, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

Takotsubo Syndrome Not Necessarily ‘Benign’ or Fleeting

Yael L. Maxwell

January 07, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2019

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Echo Overuse in Heart Failure Stabilizes in the Wake of Ontario Appropriateness Efforts

Miracor Medical Starts PiCSO-AMI-I Randomized Study in EU

Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk

Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Takotsubo Syndrome Not Necessarily ‘Benign’ or Fleeting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content